Showing results (51-60 of 104) with videos related to
Sort By:
Pageof 11
Thrombosis and Haemostasis|April 25, 1989
The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT)S G Thompson, F Duckert, F Haverkate, et al.Schweizerische Medizinische Wochenschrift|July 14, 1979
[Dissociation of human factor VIII and recombination of the fragments VIII-C and VIII-AG]T H Tran, H Bounameaux, G A Marbet, et al.Thrombosis and Haemostasis|October 31, 1980
Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor XaT H Tran, C Bondeli, G A Marbet, et al.Schweizerische Medizinische Wochenschrift|October 26, 1985
[Quantitative and qualitative hemostatic changes in 373 patients with recurring venous thromboses]G A Marbet, F Duckert, L Biland, et al.American Journal of Clinical Pathology|July 1, 1980
Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin IIIH Bounameaux, G A Marbet, B Lämmle, et al.Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1989
Ethanol elimination-rates determined by breath analysis as a marker of recent excessive ethanol consumptionH Olsen, J Sakshaug, F Duckert, et al.Thrombosis and Haemostasis|July 29, 1984
In vitro effects of the acylated streptokinase-plasminogen activator complex BRL 33 575 incubated with normal human plasmaB Lämmle, G Noll, T H Tran, et al.Current Medical Research and Opinion|January 1, 1977
Interaction study between phenprocoumon and flurbiprofenG A Marbet, F Duckert, M Walter, et al.Thrombosis and Haemostasis|December 29, 1984
Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial diseaseM Christe, A Delley, G A Marbet, et al.Lancet (London, England)|January 29, 1977
Prevention of postoperative thromboembolism by dextran 40, low doses of heparin, or xantinol nicotinateU F Gruber, F Duckert, R Fridrich, et al.Pageof 11